Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma

Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis

(2014) Shigeki Umemura et al.   Journal of Thoracic Oncology

Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

(2013) J. Le Treut et al.   ANNALS OF ONCOLOGY

A systematic review of dual targeting in HER2-positive breast cancer

(2013) Iben Kümler et al.   CANCER TREATMENT REVIEWS

The Differences of Biological Behavior Based on the Clinicopathological Data Between Resectable Large-Cell Neuroendocrine Carcinoma and Small-Cell Lung Carcinoma

(2013) Tomonari Kinoshita et al.   Clinical Lung Cancer

Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer

(2013) Eva Pros et al.   INTERNATIONAL JOURNAL OF CANCER

New Methods for ALK Status Diagnosis in Non–Small-Cell Lung Cancer: An Improved ALK Immunohistochemical Assay and a New, Brightfield, Dual ALK IHC–In Situ Hybridization Assay

(2013) Hiroaki Nitta et al.   Journal of Thoracic Oncology

Combination Chemotherapy with Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung: A Multicenter Phase II Study

(2013) Seiji Niho et al.   Journal of Thoracic Oncology

Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers

(2013) Akihiko Yoshida et al.   MODERN PATHOLOGY

Ascertaining an Appropriate Diagnostic Algorithm Using EGFR Mutation-Specific Antibodies to Detect EGFR Status in Non-Small-Cell Lung Cancer

(2013) Guiyang Jiang et al.   PLoS One

Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer

(2013) Chisato Yoshida et al.   PLoS One

A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal

(2012) G. Floris et al.   CLINICAL CANCER RESEARCH

Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients

(2012) Heae Surng Park et al.   LUNG CANCER

Chemotherapy for pulmonary large cell neuroendocrine carcinoma: Similar to that for small cell lung cancer or non-small cell lung cancer?

(2012) Jong-Mu Sun et al.   LUNG CANCER

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

(2012) Charles M Rudin et al.   NATURE GENETICS

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

(2012) Martin Peifer et al.   NATURE GENETICS

Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges

(2012) H. M. Stern   Science Translational Medicine

New targeted therapies for gastric cancer

(2011) Yoshinari Asaoka et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

(2011) Robert Pirker et al.   LANCET ONCOLOGY

PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis

(2011) N. Ilic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phase II Trial of Imatinib Maintenance Therapy After Irinotecan and Cisplatin in Patients With c-Kit–Positive, Extensive-Stage Small-Cell Lung Cancer

(2010) Bryan J. Schneider et al.   Clinical Lung Cancer

Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas

(2010) Yoh Dobashi et al.   HUMAN PATHOLOGY

Large cell/neuroendocrine carcinoma

(2010) Russell Gollard et al.   LUNG CANCER

The Combination of Multiple Receptor Tyrosine Kinase Inhibitor and Mammalian Target of Rapamycin Inhibitor Overcomes Erlotinib Resistance in Lung Cancer Cell Lines through c-Met Inhibition

(2010) I. Nakachi et al.   MOLECULAR CANCER RESEARCH

Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data

(2009) Giannis Mountzios et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Genetic changes in small cell lung carcinoma

(2008) Edurne Arriola et al.   Clinical & Translational Oncology